Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Ticagrelor FDA approval issues revisited
Victor L. Serebruany
School of Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
9
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Ticagrelor FDA approval issues revisited'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Ticagrelor
100%
Drug Approval
90%
United States Food and Drug Administration
70%
Drug Labeling
29%
Clopidogrel
23%
Acute Coronary Syndrome
20%
(1,2-diamino-4-nitrobenzene)dichloroplatinum(II)
17%
Aspirin
9%
Blood Platelets
7%
Hemorrhage
6%
Safety
5%
Pharmaceutical Preparations
4%
Therapeutics
3%